Treco Douglas A 4
4 · Inozyme Pharma, Inc. · Filed Oct 3, 2024
Insider Transaction Report
Form 4
Treco Douglas A
DirectorCEO & Chairman
Transactions
- Award
Common Stock
2024-09-30$4.45/sh+1,710$7,610→ 22,375 total
Footnotes (1)
- [F1]Shares purchased pursuant to the Inozyme Pharma, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of April 1, 2024 through September 30, 2024. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on September 30, 2024, the last trading day of the purchase period.